{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:46:02Z","timestamp":1761597962624,"version":"3.37.3"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","funder":[{"name":"Division of Intramural Research"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,22]]},"DOI":"10.1093\/infdis\/jiy430","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T06:56:23Z","timestamp":1531551383000},"page":"S658-S661","source":"Crossref","is-referenced-by-count":9,"title":["Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques"],"prefix":"10.1093","volume":"218","author":[{"given":"Kyle","family":"Rosenke","sequence":"first","affiliation":[{"name":"Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callie E","family":"Bounds","sequence":"additional","affiliation":[{"name":"Joint Program Executive Office Chemical-Biological Defense, Medical Countermeasures Systems\u2019 Joint Vaccine Acquisition Program, Fort Detrick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W","family":"Hanley","sequence":"additional","affiliation":[{"name":"Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Saturday","sequence":"additional","affiliation":[{"name":"Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie","family":"Sullivan","sequence":"additional","affiliation":[{"name":"SAB Biotherapeutics, Sioux Falls, South Dakota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[{"name":"SAB Biotherapeutics, Sioux Falls, South Dakota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-an","family":"Jiao","sequence":"additional","affiliation":[{"name":"SAB Biotherapeutics, Sioux Falls, South Dakota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Schmaljohn","sequence":"additional","affiliation":[{"name":"Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Safronetz","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana"},{"name":"Zoonotic Diseases and Special Pathogens, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"key\n\t\t\t\t2018112203552238000_CIT0001","first-page":"541","article-title":"A case of Ebola virus infection","volume":"2","author":"Emond","year":"1977","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0002","first-page":"S18","article-title":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee","volume":"179","author":"Mupapa","year":"1999","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0003","first-page":"13","article-title":"Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak","volume":"13","author":"Edwards","year":"2016","journal-title":"Clin Trials"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0004","first-page":"367","article-title":"Passive immunotherapy: assessment of convalescent serum against Ebola virus Makona infection in nonhuman primates","volume":"214","author":"Mire","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0005","first-page":"69","article-title":"The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field","volume":"62","author":"van Griensven","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0006","first-page":"33","article-title":"Evaluation of convalescent plasma for Ebola virus disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0007","first-page":"e36192","article-title":"Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever","volume":"7","author":"Marzi","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0008","first-page":"47","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0009","first-page":"138ra81","article-title":"Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0010","first-page":"18030","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0011","first-page":"5034","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0012","first-page":"e78119","article-title":"Physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle","volume":"8","author":"Sano","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0013","first-page":"e90383","article-title":"Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production","volume":"9","author":"Matsushita","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0014","first-page":"e0137786","article-title":"Human polyclonal antibodies produced through DNA vaccination of transchromosomal cattle provide mice with post-exposure protection against Lethal Zaire and Sudan Ebolaviruses","volume":"10","author":"Bounds","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0015","first-page":"360","article-title":"Efficacy of vesicular stomatitis virus-Ebola virus postexposure treatment in rhesus macaques infected with Ebola virus Makona","volume":"214","author":"Marzi","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203552238000_CIT0016","first-page":"19","article-title":"Antibody therapies for the prevention and treatment of viral infections","volume":"2","author":"Salazar","year":"2017","journal-title":"NPJ Vaccines"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/suppl_5\/S658\/26689587\/jiy430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T03:57:45Z","timestamp":1542859065000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/suppl_5\/S658\/5059678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":16,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2018,7,25]]},"published-print":{"date-parts":[[2018,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy430","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,7,25]]}}}